TP53 and acute myeloid leukemia: However, if this deletion occurs with either complex karyotypes (that is, at least three chromosomal defects) or with a TP53 gene mutation, an increased risk of transformation to AML is observed, as well as a poor prognosis, resulting in worse clinical outcomes [54,55,56].